X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (69) 69
female (57) 57
aged (43) 43
oncology (42) 42
middle aged (41) 41
adult (38) 38
breast neoplasms - drug therapy (33) 33
index medicus (29) 29
antineoplastic combined chemotherapy protocols - therapeutic use (26) 26
chemotherapy (24) 24
breast neoplasms - pathology (21) 21
male (20) 20
treatment outcome (20) 20
therapy (19) 19
breast cancer (18) 18
cyclophosphamide - administration & dosage (16) 16
prognosis (16) 16
lymphatic metastasis (15) 15
doxorubicin - administration & dosage (14) 14
survival (14) 14
antineoplastic combined chemotherapy protocols - adverse effects (13) 13
article (13) 13
cancer (13) 13
neoplasm staging (13) 13
survival analysis (13) 13
chemotherapy, adjuvant (12) 12
original reports (12) 12
time factors (12) 12
breast neoplasms - surgery (11) 11
cyclophosphamide (11) 11
age factors (10) 10
aged, 80 and over (10) 10
medicine, general & internal (10) 10
paclitaxel - administration & dosage (10) 10
risk factors (10) 10
care and treatment (9) 9
combined modality therapy (9) 9
disease-free survival (9) 9
drug administration schedule (9) 9
follow-up studies (9) 9
transplantation (9) 9
breast neoplasms - mortality (8) 8
breast neoplasms - therapy (8) 8
fluorouracil - administration & dosage (8) 8
follow-up (8) 8
prospective studies (8) 8
randomized-trial (8) 8
abridged index medicus (7) 7
adjuvant chemotherapy (7) 7
dose-response relationship, drug (7) 7
health aspects (7) 7
mastectomy (7) 7
multivariate analysis (7) 7
neoplasm metastasis (7) 7
radiotherapy (7) 7
toxicity (7) 7
trial (7) 7
adolescent (6) 6
antineoplastic combined chemotherapy protocols - administration & dosage (6) 6
bc5 (6) 6
carcinoma (6) 6
cisplatin - administration & dosage (6) 6
clinical trials (6) 6
clinical-trials (6) 6
complications and side effects (6) 6
cyclophosphamide - adverse effects (6) 6
doxorubicin - adverse effects (6) 6
paclitaxel - adverse effects (6) 6
patients (6) 6
retrospective studies (6) 6
survival rate (6) 6
women (6) 6
adjuvant treatment (5) 5
analysis (5) 5
antineoplastic agents - administration & dosage (5) 5
biomarkers, tumor - analysis (5) 5
body mass index (5) 5
cancer therapies (5) 5
diagnosis (5) 5
kaplan-meier estimate (5) 5
medical research (5) 5
neoadjuvant therapy (5) 5
neoplasm recurrence, local (5) 5
proportional hazards models (5) 5
receptors, estrogen - analysis (5) 5
risk (5) 5
stem cells (5) 5
acute disease (4) 4
breast neoplasms - chemistry (4) 4
breast neoplasms - metabolism (4) 4
breast neoplasms - radiotherapy (4) 4
cisplatin (4) 4
doxorubicin (4) 4
estrogen (4) 4
fluorouracil (4) 4
hematology (4) 4
hematopoietic stem cells (4) 4
methotrexate (4) 4
methotrexate - administration & dosage (4) 4
mortality (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 01/2015, Volume 33, Issue 1, pp. 13 - 21
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2016, Volume 34, Issue 6, pp. 542 - 549
Journal Article
Annals of Surgery, ISSN 0003-4932, 09/2015, Volume 262, Issue 3, pp. 434 - 439
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2009, Volume 360, Issue 20, pp. 2055 - 2065
This trial compared standard multiagent chemotherapy with a single agent (capecitabine) as adjuvant therapy for breast cancer in women 65 years of age or... 
SURVIVAL | TRIAL | MEDICINE, GENERAL & INTERNAL | THERAPY | CYCLOPHOSPHAMIDE | DOXORUBICIN | FOLLOW-UP | PHASE-II | DOSE-INTENSITY | CONSENSUS RECOMMENDATIONS | AGE | Breast Neoplasms - surgery | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Capecitabine | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Receptors, Estrogen - analysis | Methotrexate - therapeutic use | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Cisplatin - administration & dosage | Fluorouracil - therapeutic use | Deoxycytidine - therapeutic use | Neoplasm Metastasis | Fluorouracil - administration & dosage | Fluorouracil - adverse effects | Chemotherapy, Adjuvant - adverse effects | Aged, 80 and over | Deoxycytidine - adverse effects | Female | Doxorubicin - administration & dosage | Fluorouracil - analogs & derivatives | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Breast Neoplasms - drug therapy | Methotrexate - adverse effects | Antimetabolites, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Antimetabolites, Antineoplastic - adverse effects | Survival Analysis | Methotrexate - administration & dosage | Aged | Neoplasm Staging | Deoxycytidine - analogs & derivatives | Evaluation | Care and treatment | Usage | Aged women | Adjuvant treatment | Breast cancer | Comparative analysis | Health aspects | Cancer | Chemotherapy | Toxicity | Leukemia | Age | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Archives of Pathology & Laboratory Medicine, ISSN 0003-9985, 09/2018, Volume 142, Issue 9, pp. 1098 - 1105
(Arch Pathol Lab Med. 2018;142:1098-1105; doi: 10.5858/arpa.2017-0054-OA) Graft-versus-host disease (GVHD) of the gastrointestinal (GI) tract is a common... 
Graft-versus-host reaction | Cytomegalovirus | Transplants & implants | Laboratories | Mortality | Medical records | Histology | Patients | Consortia | Pathology | Adenoviruses | Stem cells | Endoscopy | Electronic health records | Apoptosis
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2015, Volume 33, Issue 15_suppl, pp. 1022 - 1022
Journal Article
Journal Article